| Returns | 1W : -1.7% , 1M : -4.7%,1Y : 57.8% |
| Peers & Returns | 1W | 1M | 1Y |
| CAPLIN POINT LABORATORIES LTD | -1.7% | -4.7% | 57.8% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 1.1% | -3.3% | 57.3% |
| DR REDDYS LABORATORIES LTD | 0.8% | -3.8% | 50.2% |
| DIVIS LABORATORIES LTD | 1% | -5% | 62.7% |
| CIPLA LTD | 2% | -3.5% | 89.4% |
| BIOCON LTD | -0.3% | -3.8% | 31.4% |
| AUROBINDO PHARMA LTD | -1.2% | -6.9% | 71% |
| LUPIN LTD | 0.9% | -1.8% | 61.4% |
| TORRENT PHARMACEUTICALS LTD | 1.8% | -7.4% | 16.3% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
16.16
P/E Calculated based on EPS of 28.42
[ Mar2020 - Consolidated Results ] 4.02
P/B Calculated based on Book Value of 114.21
[ Mar2020 - Consolidated Results ] 3.81
P/S Calculated based on Revenues of 910.728 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-40% -44% -40% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
